all-trans-retinol/Finding
One finding, on its own
A single claim from the graph, with the evidence strength computed from its study, the sentence it was drawn from, and the paper. This address does not change.
Decreases hospital length of stay
StrongEvidence strength: strong. Randomised human trials or their synthesis, with the effect's size and interval recorded and no recorded weakness outstanding.Findingreplicated ×3“Kiatchoosakun demonstrated a significant reduction in duration of hospital stay in the vitamin A treatment groups [mean difference (MD), −49.9; 95% CI −88.78 to −11.02; 20 infants].”
Quoted verbatim from Vitamin A to prevent bronchopulmonary dysplasia in extremely low birth weight infants: a systematic review and meta-analysis.. - Study
- meta-analysis
- Participants
- 20
- Duration
- 4 weeks
- Dose
- 5,000 IU intramuscular three times per week for 4 weeks
- Population
- Extremely low birth weight infants; a single trial (Kiatchoosakun 2014, 20 ELBW infants) was the only study in this analysis, giving vitamin A 5,000 IU intramuscularly three times per week for 4 weeks versus a sham procedure
Effect -49.9 mean difference, 95% CI -88.78 to -11.02
Vitamin A to prevent bronchopulmonary dysplasia in extremely low birth weight infants: a systematic review and meta-analysis.2018PMID:30496228Permalink
Keep reading
- Everything the graph holds on all-trans-retinol
- Every compound studied against Hospital length of stay
- How to read the evidence strength and the marks
To cite this finding: https://catalystproject.ai/e/01M5JQFT8XP6H68MEKD70BZ80B